Extensively drug resistance (XDR) tb is not always fatal.
Copyright policy )Extensively drug resistance (XDR) tb is not always fatal.
The chance of incidence of XDR TB is on the rise due to improper use of second line anti-tubercular drugs. XDR-TB is very difficult to treat successfully and is often referred to as "virtually untreatable form of TB". We herein report a case of XDR TB confirmed by bacteriological examination in a WHO recognised laboratory who after 12 months of regular treatment improved both clinically and radiologically with sputum smear conversion. To the best of our knowledge, there has been no previous report of any similar case in literature.
Adult, Male, Aza Compounds, Extensively Drug-Resistant Tuberculosis, Moxifloxacin, Antitubercular Agents, Sputum, India, Aminosalicylic Acid, Clofazimine, Injections, Treatment Outcome, Clarithromycin, Quinolines, Humans, Drug Therapy, Combination, Capreomycin, Ethambutol, Fluoroquinolones
Adult, Male, Aza Compounds, Extensively Drug-Resistant Tuberculosis, Moxifloxacin, Antitubercular Agents, Sputum, India, Aminosalicylic Acid, Clofazimine, Injections, Treatment Outcome, Clarithromycin, Quinolines, Humans, Drug Therapy, Combination, Capreomycin, Ethambutol, Fluoroquinolones
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).2 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!